GENEVA, Sept. 18 -- CRINETICS PHARMACEUTICALS, INC. filed a patent application (US2026/017309) for “USES OF A SOMATOSTATIN MODULATOR FOR THE TREATMENT OF CARCINOID SYNDROME”. With publication no. WO/2026/187675, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/4709
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....